Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-NUDT2 (1-147) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
NUDT2 |
Gene ID: |
318 |
Uniprot ID: |
AP4A_HUMAN |
Immunogen Region: |
1-147 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-147 of human NUDT2 (NP_001152.1). |
Immunogen Sequence: |
MALRACGLIIFRRCLIPKVD NNAIEFLLLQASDGIHHWTP PKGHVEPGEDDLETALRETQ EEAGIEAGQLTIIEGFKREL NYVARNKPKTVIYWLAEVKD YDVEIRLSHEHQAYRWLGLE EACQLAQFKEMKAALQEGHQ FLCSIEA |
Function | Catalyzes the asymmetric hydrolysis of diadenosine 5',5'''-P1,P4-tetraphosphate (Ap4A) to yield AMP and ATP. Exhibits decapping activity towards FAD-capped RNAs and dpCoA-capped RNAs in vitro. |
Protein Name | Bis(5'-Nucleosyl-Tetraphosphatase AsymmetricalDiadenosine 5' -5'''-P1 -P4-Tetraphosphate Asymmetrical HydrolaseAp4a HydrolaseAp4aaseDiadenosine TetraphosphataseNucleoside Diphosphate-Linked Moiety X Motif 2Nudix Motif 2 |
Database Links | Reactome: R-HSA-3299685 |
Alternative Antibody Names | Anti-Bis(5'-Nucleosyl-Tetraphosphatase Asymmetrical antibodyAnti-Diadenosine 5' -5'''-P1 -P4-Tetraphosphate Asymmetrical Hydrolase antibodyAnti-Ap4a Hydrolase antibodyAnti-Ap4aase antibodyAnti-Diadenosine Tetraphosphatase antibodyAnti-Nucleoside Diphosphate-Linked Moiety X Motif 2 antibodyAnti-Nudix Motif 2 antibodyAnti-NUDT2 antibodyAnti-APAH1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance